BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23282866)

  • 1. The pathophysiology of hereditary angioedema.
    Zuraw BL
    World Allergy Organ J; 2010 Sep; 3(9 Suppl):S25-8. PubMed ID: 23282866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of hereditary angioedema.
    Zuraw BL; Christiansen SC
    Am J Rhinol Allergy; 2011; 25(6):373-8. PubMed ID: 22185738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HAE Pathophysiology and Underlying Mechanisms.
    Zuraw BL; Christiansen SC
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary angioedema in childhood: an approach to management.
    Ebo DG; Verweij MM; De Knop KJ; Hagendorens MM; Bridts CH; De Clerck LS; Stevens WJ
    Paediatr Drugs; 2010 Aug; 12(4):257-68. PubMed ID: 20593909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hereditary angioedema-single or multiple pathways to the rescue.
    Valerieva A; Longhurst HJ
    Front Allergy; 2022; 3():952233. PubMed ID: 36172291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current update on cellular and molecular mechanisms of hereditary angioedema.
    Walford HH; Zuraw BL
    Ann Allergy Asthma Immunol; 2014 May; 112(5):413-8. PubMed ID: 24484972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
    Busse P; Kaplan A
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema.
    Loffredo S; Bova M; Suffritti C; Borriello F; Zanichelli A; Petraroli A; Varricchi G; Triggiani M; Cicardi M; Marone G
    Allergy; 2016 Jul; 71(7):989-96. PubMed ID: 26873113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genetics of Hereditary Angioedema: A Review.
    Santacroce R; D'Andrea G; Maffione AB; Margaglione M; d'Apolito M
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34065094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).
    Wedner HJ
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
    Guo Y; Zhang H; Lai H; Wang H; Chong-Neto HJ; Valle SOR; Zhu R
    Orphanet J Rare Dis; 2022 Nov; 17(1):399. PubMed ID: 36324138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multifactorial impact of receiving a hereditary angioedema diagnosis.
    Raasch J; Glaum MC; O'Connor M
    World Allergy Organ J; 2023 Jun; 16(6):100792. PubMed ID: 37448849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Immune Cells in Hereditary Angioedema.
    Ferrara AL; Cristinziano L; Petraroli A; Bova M; Gigliotti MC; Marcella S; Modestino L; Varricchi G; Braile M; Galdiero MR; Spadaro G; Loffredo S
    Clin Rev Allergy Immunol; 2021 Jun; 60(3):369-382. PubMed ID: 34050913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor.
    Bova M; Suffritti C; Bafunno V; Loffredo S; Cordisco G; Del Giacco S; De Pasquale TMA; Firinu D; Margaglione M; Montinaro V; Petraroli A; Radice A; Brussino L; Zanichelli A; Zoli A; Cicardi M
    Allergy; 2020 Jun; 75(6):1394-1403. PubMed ID: 31860755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
    Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
    Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Approaches for Assessing Contact System Activation.
    Christiansen SC; Zuraw BL
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):527-539. PubMed ID: 28687107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.